Care-continuity AI · Abu Dhabi

From screening to
sustained care.

Azorva is the AI continuity layer that turns the UAE's health data into daily action, flagging who needs follow-up, reaching them in their own language, and closing every care loop with a doctor in control.

Human-in-the-loop·22 languages·Built for Malaffi, Riayati & Nabidh
Screen Confirm Treat Refill Review Control
Scroll
Built to integrate with the UAE health system
Malaffi Riayati Nabidh Weqaya / IFHAS Emirati Genome Programme
Integration targets, shown for context, not endorsements.
The problem

The UAE screens at scale. It still can't close the loop.

Millions are screened for diabetes and cardiovascular disease every year. But between a flagged result and a controlled patient, people slip through, and the system can't see who.

~20%
of adults live with diabetes
Up to 1 in 4 among Emiratis.
#1
cause of death is cardiovascular disease
Around 34% of all deaths.
~AED 40bn
annual economic burden of non-communicable disease
Rising with every uncontrolled year.
~68%
of adults are overweight
The pipeline of future disease.

A citizen can be screened, diagnosed and prescribed, and still be lost before their disease is ever controlled.

The solution

One accountable loop, in two layers.

Layer one turns every patient into a structured, risk-flagged record and a clear clinical pathway. Layer two chases down everyone who is still unresolved, and closes nothing until the loop completes.

Layer 1 Intake & Clinical Decision Support
Patient
At the PHC or screening clinic
Tablet intake
Emirates ID · Malaffi lookup
Azorva AI engine
Structures & risk-flags the record
Physician review
GP confirms the pathway
Pathway General care Tests Specialist Emergency
AI supports, the physician decides.
How it works

One patient, from vitals to control.

1
Capture

A worker captures the vitals.

A community health worker records blood pressure, glucose and history on the tablet, in the patient's own language, linked to their Emirates ID.

2
Prioritise

Azorva ranks today's risk.

The engine structures the record, flags the risk, and places the patient on today's prioritised list, always with the reason attached.

3
Reach

The patient is contacted in their language.

AI voice or SMS reaches them, a refill reminder, a re-test, or an escalation, and logs exactly what they said back.

4
Confirm

A clinician approves the action.

A GP reviews, approves or adjusts, and only then does the loop close. Care is confirmed, not assumed.

AH
Amina H.
PHC · Al Ain · ID ••• 4821
HIGH RISK
01 / 04 · Capturing vitals
Blood pressure148 / 94
Fasting glucose9.2 mmol/L
On medicationYes · 6 mo

Not "how many were screened", but "who is still uncontrolled, and why."

The AI

The intelligence between screening and control.

Azorva is an AI company with a clinical spine. Four capabilities carry a patient from a flagged result to confirmed control.

Risk-prioritisation engine

Ranks every unresolved patient by clinical urgency each day, and shows the reason behind the rank.

Multilingual voice AI

Natural conversational voice, IVR and SMS in 22 languages, outreach that lands in the patient's own words.

PHASE 2

Genomic-risk-aware targeting

As Emirati Genome signals come online, Azorva sharpens who to reach first, before disease takes hold.

Human-in-the-loop by design

Every action is auditable and clinician-approved. The AI proposes, a licensed physician decides.

One conversation · 22 languages

We speak the language your population lives in.

Why different

The difference is a loop that actually closes.

Most tools show activity. Azorva shows accountability, every unresolved patient has an owner, a reason and a next step.

Before Azorva
With Azorva
Long manual recall lists
Daily prioritised list, with reasons
Abnormal screens quietly get lost
Closed-loop tracking on every result
Refill gaps go unseen
Refill & stock alerts, ahead of time
Referrals end in uncertainty
Referral tickets closed or escalated
Dashboards of activity, how many
Control, retention & equity, who
Operating model

Clinical accountability and secure delivery, by design.

01
Clinical governance
Doctor-controlled pathways
Clinical decisions remain with authorised care teams.
Human approval at critical steps
Measurable care-loop outcomes
Clear escalation ownership
02
Secure engineering
Least-privilege systems
Minimal exposure, monitored boundaries, and controlled change.
Private cloud origins
Strict browser isolation
Abuse filtering and alerts
03
UAE delivery
Bounded enterprise pilots
Scoped rollout, agreed measures, and accountable operations.
Defined pilot boundary
Operational handover and review
Request a pilot

Bring Azorva to your population.

Tell us about your organisation and we'll design a bounded pilot with clear, measurable outcomes.

Bounded scope, measurable outcomes
Human-in-the-loop, clinician-approved
Built to integrate, not replace
Please do not include patient names, medical records, or other health information.
We reply within two business days. No newsletters, no spam.